ClinicalTrials.gov
ClinicalTrials.gov Menu

Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients (RP_MPR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01160107
Recruitment Status : Active, not recruiting
First Posted : July 12, 2010
Last Update Posted : August 1, 2017
Sponsor:
Information provided by (Responsible Party):
Fondazione Neoplasie Sangue Onlus

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : August 2012
  Estimated Study Completion Date : August 2019